Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Specific monoclonal antibodies against IDH1/2 mutations as diagnostic tools for gliomas.

Kato Y.

Brain Tumor Pathol. 2015 Jan;32(1):3-11. doi: 10.1007/s10014-014-0202-4. Epub 2014 Oct 17. Review.

PMID:
25324168
2.

Novel monoclonal antibodies GMab-r1 and LMab-1 specifically recognize IDH1-R132G and IDH1-R132L mutations.

Kaneko MK, Tsujimoto Y, Hozumi Y, Goto K, Kato Y.

Monoclon Antib Immunodiagn Immunother. 2013 Jun;32(3):224-8. doi: 10.1089/mab.2013.0006.

PMID:
23750482
3.

A novel monoclonal antibody GMab-m1 specifically recognizes IDH1-R132G mutation.

Kato Y, Natsume A, Kaneko MK.

Biochem Biophys Res Commun. 2013 Mar 22;432(4):564-7. doi: 10.1016/j.bbrc.2013.02.049. Epub 2013 Feb 26.

PMID:
23485467
4.

Establishment of novel monoclonal antibodies KMab-1 and MMab-1 specific for IDH2 mutations.

Kaneko MK, Morita S, Tsujimoto Y, Yanagiya R, Nasu K, Sasaki H, Hozumi Y, Goto K, Natsume A, Watanabe M, Kumabe T, Takano S, Kato Y.

Biochem Biophys Res Commun. 2013 Mar 1;432(1):40-5. doi: 10.1016/j.bbrc.2013.01.088. Epub 2013 Jan 31.

PMID:
23376717
5.

Immunohistochemical detection of IDH1 mutation, p53, and internexin as prognostic factors of glial tumors.

Takano S, Kato Y, Yamamoto T, Kaneko MK, Ishikawa E, Tsujimoto Y, Matsuda M, Nakai K, Yanagiya R, Morita S, Tsuboi K, Matsumura A.

J Neurooncol. 2012 Jul;108(3):361-73. doi: 10.1007/s11060-012-0837-0. Epub 2012 Mar 7.

PMID:
22396072
6.

Establishment of a novel monoclonal antibody SMab-1 specific for IDH1-R132S mutation.

Kaneko MK, Tian W, Takano S, Suzuki H, Sawa Y, Hozumi Y, Goto K, Yamazaki K, Kitanaka C, Kato Y.

Biochem Biophys Res Commun. 2011 Mar 25;406(4):608-13. doi: 10.1016/j.bbrc.2011.02.102. Epub 2011 Feb 23.

PMID:
21352804

Supplemental Content

Loading ...
Support Center